NCT01187355

Brief Summary

The purpose of this study is to compare two contact lens care solutions in symptomatic wearers of silicone hydrogel contact lenses.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
591

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jul 2010

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2010

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

August 20, 2010

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 24, 2010

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2011

Completed
1.6 years until next milestone

Results Posted

Study results publicly available

July 30, 2012

Completed
Last Updated

July 30, 2012

Status Verified

June 1, 2012

Enrollment Period

6 months

First QC Date

August 20, 2010

Results QC Date

June 26, 2012

Last Update Submit

June 26, 2012

Conditions

Keywords

Symptomatic, Contact lens careMulti-purpose solution

Outcome Measures

Primary Outcomes (1)

  • Likert Statement: When I Use This Solution, I Can Comfortably Wear my Lenses.

    As interpreted and reported by the subject on a questionnaire as a single, retrospective evaluation of the last three days of wearing experience. A 5-point Likert scale was used, where 1=strongly disagree, 2=disagree; 3=neither disagree nor agree; 4=agree; 5=strongly agree.

    Day 30

Secondary Outcomes (2)

  • Likert Statement: When I Use This Solution, My Lenses Are Comfortable From Morning Until Evening.

    Day 30

  • Likert Statement: When I Use This Solution, I Forget I am Wearing my Lenses.

    Day 30

Study Arms (2)

Alcon MPDS

EXPERIMENTAL

MPDS used for 30 days as specified in protocol for contact lens care.

Device: FID 114675A Multi-Purpose Disinfecting Solution (MPDS)Device: Contact lenses

renu fresh MPS

ACTIVE COMPARATOR

MPS used for 30 days as indicated for contact lens care.

Device: renu fresh Multi-Purpose Solution (MPS)Device: Contact lenses

Interventions

Investigational multi-purpose disinfecting solution used by subjects as specified in use instructions provided for the care of study contact lenses, 30 days.

Alcon MPDS

Commercially available multi-purpose solution used by subjects as indicated for care of study contact lenses, 30 days.

Also known as: renu® fresh™ Multi-Purpose Solution
renu fresh MPS

Contact lenses per subject's habitual brand and power worn for 30 days on a daily wear basis.

Alcon MPDSrenu fresh MPS

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Symptomatic silicone hydrogel contact lens wearers who wear their lenses daily wear (i.e., disinfect lenses every night).
  • Vision correctable to 20/30 or better with contact lenses.

You may not qualify if:

  • Sensitivity to multi-purpose solutions.
  • Use of any topical ocular OTC or prescribed topical ocular medications.
  • History (6 months) or current ocular infections or ocular inflammatory events.
  • Ocular surgery within the past year.
  • Medical condition or use of medications that cause ocular side effects.
  • Participation in any investigational study within the past 30 days.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Contact Alcon Call Center for Trial Locations

Fort Worth, Texas, 76134, United States

Location

MeSH Terms

Interventions

Contact Lenses

Intervention Hierarchy (Ancestors)

LensesOptical DevicesEquipment and Supplies

Results Point of Contact

Title
Director of Alcon Clinical
Organization
Alcon Research, Ltd.

Publication Agreements

PI is Sponsor Employee
No
Restriction Type
OTHER
Restrictive Agreement
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 20, 2010

First Posted

August 24, 2010

Study Start

July 1, 2010

Primary Completion

January 1, 2011

Study Completion

January 1, 2011

Last Updated

July 30, 2012

Results First Posted

July 30, 2012

Record last verified: 2012-06

Locations